Rocatinlimab is an investigational medication being studied for treating prurigo nodularis, a skin condition that causes intense itching and nodules on the skin. This medication is designed to help patients who haven’t responded well to topical treatments (creams or ointments applied to the skin) or who cannot use topical treatments. It works by targeting specific components of the immune system that are involved in causing the intense itching and skin lesions associated with prurigo nodularis.

Topical therapies refer to various creams, ointments, or lotions that are applied directly to the skin to treat prurigo nodularis. These are standard treatments that patients may have used before trying rocatinlimab.

Prurigo Nodularis – A chronic skin condition characterized by hard, itchy nodules (bumps) that develop on the skin. The condition typically begins with an intense itching sensation that leads to scratching, which then causes the formation of firm, dome-shaped bumps on the skin’s surface. These nodules commonly appear on the arms, legs, upper back, and abdomen. The affected areas often become rough and thickened due to repeated scratching. The condition can persist for months or years, with periods of improvement and worsening. The itching associated with Prurigo Nodularis can be severe and often interferes with daily activities and sleep.